| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Analysis of PD-L1 promoter methylation combined with immunogenic context in pancreatic ductal adenocarcinoma
|
Chen, Xinyuan
|
|
|
73 |
8 |
|
artikel
|
| 2 |
A novel liver-function-indicators-based prognosis signature for patients with hepatocellular carcinoma treated with anti-programmed cell death-1 therapy
|
Zheng, Zehao
|
|
|
73 |
8 |
|
artikel
|
| 3 |
Clinical outcomes and biomarker exploration of first-line PD-1 inhibitors plus chemotherapy in patients with low PD-L1-expressing of gastric or gastroesophageal junction adenocarcinoma
|
Sun, Yu-Ting
|
|
|
73 |
8 |
|
artikel
|
| 4 |
Combinational zimberelimab plus lenvatinib and chemotherapy for alpha-fetoprotein elevated, advanced gastric cancer patients (AFPGC): a phase 1 dose-escalation study
|
Deng, Ting
|
|
|
73 |
8 |
|
artikel
|
| 5 |
Combination of STING agonist with anti-vascular RGD-(KLAKLAK)2 peptide as a novel anti-tumor therapy
|
Czapla, Justyna
|
|
|
73 |
8 |
|
artikel
|
| 6 |
Combined use of tyrosine kinase inhibitors with PD-(L)1 blockade increased the risk of thyroid dysfunction in PD-(L)1 blockade: a prospective study
|
Kobayashi, Tomoko
|
|
|
73 |
8 |
|
artikel
|
| 7 |
Comprehensive analysis of the relationship between ubiquitin-specific protease 21 (USP21) and prognosis, tumor microenvironment infiltration, and therapy response in colorectal cancer
|
Nie, Haihang
|
|
|
73 |
8 |
|
artikel
|
| 8 |
Efficacy and safety of anti-PD-1/PD-L1-based dual immunotherapies versus PD-1/PD-L1 inhibitor alone in patients with advanced solid tumor: a systematic review and meta-analysis
|
Chen, Yueying
|
|
|
73 |
8 |
|
artikel
|
| 9 |
Efficacy and safety of immune checkpoint inhibitors in solid tumor patients combined with chronic coronary syndromes or its risk factor: a nationwide multicenter cohort study
|
Liu, Chao
|
|
|
73 |
8 |
|
artikel
|
| 10 |
Enhanced abscopal anti-tumor response via a triple combination of thermal ablation, IL-21, and PD-1 inhibition therapy
|
Wu, Shaoxian
|
|
|
73 |
8 |
|
artikel
|
| 11 |
Evaluation of the clinical application value of cytokine expression profiles in the differential diagnosis of prostate cancer
|
Chen, Rongfa
|
|
|
73 |
8 |
|
artikel
|
| 12 |
Identification of an HLA-A*11:01-restricted neoepitope of mutant PIK3CA and its specific T cell receptors for cancer immunotherapy targeting hotspot driver mutations
|
Shen, Meiying
|
|
|
73 |
8 |
|
artikel
|
| 13 |
Impact of cemiplimab treatment duration on clinical outcomes in advanced cutaneous squamous cell carcinoma
|
Mallardo, Domenico
|
|
|
73 |
8 |
|
artikel
|
| 14 |
Inhibition of glycolysis enhances the efficacy of immunotherapy via PDK-mediated upregulation of PD-L1
|
Zhang, Ruizhi
|
|
|
73 |
8 |
|
artikel
|
| 15 |
Integration of deep learning and habitat radiomics for predicting the response to immunotherapy in NSCLC patients
|
Caii, Weimin
|
|
|
73 |
8 |
|
artikel
|
| 16 |
MB2033, an anti-PD-L1 × IL-2 variant fusion protein, demonstrates robust anti-tumor efficacy with minimal peripheral toxicity
|
Park, Young Jin
|
|
|
73 |
8 |
|
artikel
|
| 17 |
Oligo-residual disease in PD-1/PD-L1 inhibitor-treated metastatic non-small cell lung cancer: incidence, pattern of failure, and clinical value of local consolidative therapy
|
Zhang, Jinmeng
|
|
|
73 |
8 |
|
artikel
|
| 18 |
Prognostic value of genomic mutation signature associated with immune microenvironment in southern Chinese patients with esophageal squamous cell carcinoma
|
Zhou, Yue
|
|
|
73 |
8 |
|
artikel
|
| 19 |
Rocaglamide promotes infiltration and differentiation of T cells and coordinates with PD-1 inhibitor to overcome checkpoint resistance in multiple tumor models
|
Luo, Jiaojiao
|
|
|
73 |
8 |
|
artikel
|
| 20 |
Sex and survival outcomes in patients with renal cell carcinoma receiving first-line immune-based combinations
|
Incorvaia, Lorena
|
|
|
73 |
8 |
|
artikel
|
| 21 |
SIRPG expression positively associates with an inflamed tumor microenvironment and response to PD-1 blockade
|
Luo, Libo
|
|
|
73 |
8 |
|
artikel
|
| 22 |
The biological roles of CD47 in ovarian cancer progression
|
Xing, Linan
|
|
|
73 |
8 |
|
artikel
|
| 23 |
The VISTA/VSIG3/PSGL-1 axis: crosstalk between immune effector cells and cancer cells in invasive ductal breast carcinoma
|
Olbromski, Mateusz
|
|
|
73 |
8 |
|
artikel
|
| 24 |
Two nomograms constructed for predicting the efficacy and prognosis of advanced non‑small cell lung cancer patients treated with anti‑PD‑1 inhibitors based on the absolute counts of lymphocyte subsets
|
Liu, Aqing
|
|
|
73 |
8 |
|
artikel
|
| 25 |
USP47 deficiency in mice modulates tumor infiltrating immune cells and enhances antitumor immune responses in prostate cancer
|
Wang, Qian-Lan
|
|
|
73 |
8 |
|
artikel
|
Tijdschrift beschrijving